SAGE

Clinical Medicine Reviews in Therapeutics Template

Write in a clean editor, then format for Clinical Medicine Reviews in Therapeutics in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the Clinical Medicine Reviews in Therapeutics format

Clinical Medicine Reviews in Therapeutics is a peer-reviewed journal published by SAGE, covering Antibiotics Pharmacokinetics and Efficacy, Antimicrobial Resistance in Staphylococcus, Antibiotic Resistance in Bacteria.

PublisherSAGE
Reference styleAuthor–year (Harvard)
Author–year — (Smith, 2023) in the text
Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Clinical Medicine Reviews in Therapeutics, 12(3), pp. 45–58.

Formats any DOI in Clinical Medicine Reviews in Therapeutics style. No sign-up.

Publishes research inAntibiotics Pharmacokinetics and Efficacy Antimicrobial Resistance in Staphylococcus Antibiotic Resistance in Bacteria Pneumonia and Respiratory Infections Asthma and respiratory diseases
ISSN1179-2558
h-index5
i10-index4
Total citations228
Top institutions publishing hereUniversity of Minnesota
Journal websiteclockss.org
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Clinical Medicine Reviews in Therapeutics per year

2
2009
28
2010
30
2011
10
2012
2
2013
2
2014
2
2015
3
2016
3
2017
1
2018

Citation impact of Clinical Medicine Reviews in Therapeutics by publication year

1
2009
58
2010
151
2011
1
2012
0
2013
2
2014
4
2015
3
2016
3
2017
4
2018

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Clinical Medicine Reviews in Therapeutics

Ceftaroline: A New Cephalosporin with Activity Against Methicillin-Resistant Staphylococcus aureus (MRSA)

Christopher Duplessis, Nancy F. Crum‐Cianflone · 1 Jan 2011

Microbial resistance has reached alarming levels, threatening to outpace the ability to counter with more potent antimicrobial agents. In particular, methicillin-resistant Staphylococcus aureus (MRSA) has become a leading cause of skin and soft-tissue infections and PVL-positive strains have been associated with necrotizing pneumonia. Increasing reports of growing resistance to glycopeptides have been noted, further limiting…

Zidovudine and Lamivudine for HIV Infection

Peter L. Anderson, Joseph E. Rower · 1 Jan 2010

Zidovudine and lamivudine (ZDV and 3TC) are long-standing nucleoside analog-reverse transcriptase inhibitors (NRTIs) with extensive clinical experience in a wide spectrum of patients from in utero through childhood and adult ages. The safety profiles of both drugs are well-known and side effects for ZDV most commonly include nausea/vomiting, fatigue, anemia/neutopenia, and lipoatrophy; while 3TC is…

Hyaluronic Acid Dermal Fillers: Safety and Efficacy for the Treatment of Wrinkles, Aging Skin, Body Sculpturing and Medical Conditions

Uwe Wollina and Alberto Goldman · 1 Jan 2011

Hyaluronic acid (HA) is a linear naturally occurring polysaccharide formed from repeating disaccharide units of N-acetyl-D-glucosamine and D-glucuronate. HA is omnipresent in the human body but highest amounts are found in soft connective tissues. HA is involved in several key processes, including wound repair, regeneration, and matrix organization. To increase stability, modifications of HA like…

Raltegravir in HIV-1 Infection: Safety and Efficacy in Treatment-Naïve Patients

Krishan K. Pandey · 20 Dec 2011

The hunt for a compound which inhibits the HIV-1 integrase had been painstakingly difficult. Integrase is essential for viral replication as it mediates the integration of the viral DNA genome into the host DNA resulting in the establishment of the permanent provirus. Persistent efforts have resulted in the discovery of Raltegravir (Isentress, MK-0518), the first…

Fosfomycin and Its Application in the Treatment of Multidrug-Resistant Enterobacteriaceae Infections

1 Jan 2011

The use of fosfomycin has been limited in therapeutics in recent years. Because it has shown good antibacterial activity in vitro and clinical efficacy in some domains, it has been proposed as an alternative to current antimicrobial agents, which are subject to increasing resistance. This paper reviews the main properties of fosfomycin and the latest…

Clinical Medicine Reviews in Therapeutics template — frequently asked questions

How do I write a paper in the Clinical Medicine Reviews in Therapeutics format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Clinical Medicine Reviews in Therapeutics template. When you export, DocuGuru compiles the paper into the official SAGE format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Clinical Medicine Reviews in Therapeutics use?
Clinical Medicine Reviews in Therapeutics uses Author–year (Harvard) references, shown as author–year markers such as (Smith, 2023) in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Clinical Medicine Reviews in Therapeutics, 12(3), pp. 45–58.
Do I need to know LaTeX to submit to Clinical Medicine Reviews in Therapeutics?
No. DocuGuru generates the sagej LaTeX class and compiles the PDF for you in the background, so you get a SAGE-ready Clinical Medicine Reviews in Therapeutics document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Clinical Medicine Reviews in Therapeutics template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Clinical Medicine Reviews in Therapeutics format with correct headings, figures, tables, and author–year citations.
Who publishes Clinical Medicine Reviews in Therapeutics?
Clinical Medicine Reviews in Therapeutics is a multidisciplinary journal published by SAGE. DocuGuru's Clinical Medicine Reviews in Therapeutics template matches SAGE's official submission format.
Can I export a submission-ready Clinical Medicine Reviews in Therapeutics PDF?
Yes — DocuGuru produces a PDF built with the official Clinical Medicine Reviews in Therapeutics template (the sagej class) that is ready to submit to SAGE, together with the matching LaTeX source files.
How much does the Clinical Medicine Reviews in Therapeutics template cost?
You can start writing in the Clinical Medicine Reviews in Therapeutics template for free. Exporting the final submission-ready Clinical Medicine Reviews in Therapeutics PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Clinical Medicine Reviews in Therapeutics template